3758 results for «2020»
3758 results
Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer
22 May 2025 – From EuroPCR 2025
Refractory angina affects more than 100 million people globally and is associated with a significantly increased risk of adverse cardiovascular events. Treating this condition effectively remains a major clinical challenge. This session provides detailed insights into the use of the Shockwave Reducer device as an innovative therapeutic...
Antithrombotic drugs for acute coronary syndromes in women
21 May 2025 – From EuroPCR 2025
Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting...
Critical limb ischaemia below the knee treatment
21 May 2025 – From EuroPCR 2025
This session focuses on advanced techniques for treating critical limb ischaemia below the knee. Understand how to select wires for antegrade recanalisation, the role and timing of retrograde access, and the potential benefits of drug-coated balloons in below-the-knee angioplasty.
Transcatheter tricuspid valve replacement in the real world: current data and outcomes
21 May 2025 – From EuroPCR 2025
Explore current real-world data and outcomes of transcatheter tricuspid valve replacement (TTVR). This session reviews UK single-centre experiences, registry data, long-term right ventricular remodeling effects, safety in pacemaker patients, and AI-based CT screening for patient selection.
Managing challenging vasculature to successfully deliver TAVI
21 May 2025 – From EuroPCR 2025
This session addresses the challenges of delivering TAVI in patients with complex vascular anatomy. Explore expert strategies for performing TAVI post-coarctation surgery, valve-in-valve procedures, and managing difficult aortic arch anatomies including bicuspid valves with large annuli and tortuous vessels.
Enhancing knowledge in diagnosis ANOCA
21 May 2025 – From EuroPCR 2025
Enhance your understanding of the diagnosis of ANOCA through advanced diagnostic techniques. Topics include coronary endothelial function assessment, exercise stress testing for microvascular dysfunction, acetylcholine-induced coronary responses, and the clinical implications of myocardial bridge in provocative testing.
High-risk left main PCI
21 May 2025 – From EuroPCR 2025
Delve into the complexities of high-risk left main PCI with a focus on procedural planning and managing unexpected challenges such as spontaneous coronary artery dissection. Learn valuable strategies including contingency planning to optimize outcomes in complex interventions.
Management of heavy calcified bifurcation lesions
21 May 2025 – From EuroPCR 2025
This session focuses on the management of heavily calcified bifurcation lesions using advanced techniques such as IVUS guided guidewire recrossing and orbital atherectomy. Learn step-by-step approaches to tackle complex calcific coronary bifurcations and improve procedural success.
My worst PCI complication: how did I treat and could I have prevented it?
21 May 2025 – From EuroPCR 2025
Learn practical strategies to manage life-threatening PCI complications through real case studies. This session highlights techniques and devices employed to overcome complications, preventive measures, and safe outcome optimization during complex interventions.
Tips for challenging TAVI scenarios
21 May 2025 – From EuroPCR 2025
Explore expert tips for navigating challenging TAVI scenarios including cases with stent entrapment, extremely large annuli, and rare anatomical conditions like Klippel Feil syndrome. Understand approaches for intraannular valve prosthesis implantation in complex coronary anatomy.
How to deal with left main culprit in NSTEMI
21 May 2025 – From EuroPCR 2025
This session offers a cross-geographic exchange on managing left main culprit lesions in NSTEMI patients. Learn different interventional approaches, risk evaluation for periprocedural complications, and diverse PCI management strategies tailored to this complex subgroup.
Chronic coronary syndrome with low ejection fraction and left ventricle support
21 May 2025 – From EuroPCR 2025
This session examines the management of chronic coronary syndrome in patients with low ejection fraction, emphasizing the role of left ventricular support. Topics include risks of intracoronary imaging, pharmacological facilitation, mechanical circulatory support, and alternatives like LAVA-ECMO.
Through decisions in complex left main PCI - Isolated ostial left circumflex
21 May 2025 – From EuroPCR 2025
Navigate complex isolated ostial left circumflex lesions with a focus on the integration of imaging and physiological assessment. Learn treatment options and optimisation strategies to improve long-term outcomes in left main PCI through detailed case presentations and expert guidance.
Coronary dissection : when imaging makes the difference
21 May 2025 – From EuroPCR 2025
Explore the critical role of intracoronary imaging in diagnosing and managing coronary dissections and related complications. Through case studies, learn about bailout strategies and the domino effect of decisions during PCI in acute myocardial infarction.
DCB in challenging scenarios - Part 2
20 May 2025 – From EuroPCR 2025
Explore the application of drug-coated balloons (DCB) in challenging coronary scenarios with a focus on recurrent calcified stenosis, in-stent restenosis, and left main interventions. This session includes case discussions on plaque phenotype-guided DCB treatment, 'leave nothing behind' strategy, and complex left main PCI using kissing DCBs...
LoDoCo2 - Low-dose colchicine in coronary disease
02 Sep 2020
Reported from ESC Congress 2020 - Massimo Imazio (Turin, Italy) discusses with Dejan Milasinovic the results of the LoDoCo2 trial which showed that Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease.
Author
STS/ACC TVT Registry: Cerebral embolic protection and TAVR outcomes
19 Oct 2020
At TCT Connect 2020, David J. Cohen (Kansas City, Missouri, USA) presented results from an analysis of the TVT registry focusing on impact of Cerebral Embolic Protection (CEP) on TAVR outcomes. Nicolas Dumonteil provides a summary of the key messages.
Author
COMPARE CRUSH: A randomized trial of prehospital crushed vs uncrushed prasugrel in STEMI
20 Oct 2020
Luis Ortega-Paz provides a summary of the key messages from the COMPARE CRUSH trial. He also discusses the main findings and recommendations in clinical practice with Georgios Vlachojannis who presented the results during TCT Connect 2020.
Author
COVID-19: Providing ongoing care to patients with cardiovascular disease in a pandemic
20 Mar 2020
The world is facing unprecedented challenges as a result of a bug called COVID-19 (Sars-CoV-2) that has literally gone “viral” across the globe affecting >250K individuals in 183/195 countries, claiming >10,000 lives in a short period of time (as of 15:00 20/3/2020).
Author
SCOPE II: A randomized trial of two self-expanding TAVR bioprostheses
18 Oct 2020
At TCT Connect 2020, Late-Breaking Trial Session II, the primary results of the Safety and Efficacy Comparison of Two TAVI Systems in a Prospective Randomized Evaluation (SCOPE) 2 trial were presented and simultaneously published in Circulation. Daniele Giacoppo provides a summary of the trial.
Author
